Business Wire

New Investment Tracker: EU Cleantech Investments Shatter Records; €7 Billion Invested in First Half of This Year

8.7.2021 10:49:00 EEST | Business Wire | Press release

Share

Cleantech for Europe, a new initiative created by Cleantech Group, supported by Breakthrough Energy, today presented its first ‘EU Quarterly Cleantech Briefing’. The analysis finds that in the first half of this year more than €7 billion of venture capital was invested in cleantech innovation in the European Union (EU). With six months remaining in 2021, this figure has already beaten the previous annual record for Europe, set just last year at €4.7 billion.

In view of this momentum, Cleantech for Europe will bring together top cleantech leaders from VCs, startups, academia, and civil society to build much-needed bridges with policymakers in Brussels and other European capitals. In a first instance, six leading cleantech venture capital firms, regarded as pioneers in financing innovative low-carbon companies, are joining the initiative. Other communities from start-ups, scale-ups, academia and civil society will join the initiative over time to build a future-oriented, technology-savvy group of cleantech leaders from across the EU.

The six “Cleantech for Europe Leaders” are: Beamline Accelerator (Estonia), btov Industrial Tech Fund (Germany), Inven Capital (Czech Republic), Munich Venture Partners (Germany), Rockstart (Netherlands), and SET Ventures (Netherlands). Combined, these firms have invested in more than 150 innovative low-carbon start-ups and scale-ups, including global leaders such as Sonnen in batteries and Sunfire in hydrogen production. For the first time, these firms are coming together to build a collective voice and convey to policymakers and other stakeholders the importance of investing in the next generation of clean technologies.

Despite the fact that EU cleantech investments are booming compared to previous years, the EU Quarterly Cleantech Briefing notes they may still fall short of what is needed to ensure EU start-ups can scale up across the continent. In the past decade, EU companies seeking to scale have often turned toward Asia or North America for larger markets, more abundant funding and ambitious public policies that accelerate their adoption.

“This analysis illustrates the extraordinary progress of the EU’s cleantech ecosystem – and the mountain of urgent work that lies ahead, particularly around helping build an EU policy framework that prioritizes and supports cleantech innovation.” said Ann Mettler, Vice President Europe at Breakthrough Energy, an organization founded by Bill Gates to support the innovations that will lead the world to net-zero emissions.

The release of the investment tracker and the announcement of the Cleantech for Europe initiative come just days before the EU prepares to unveil its highly anticipated “Fit for 55” package of climate legislation, and as most EU member states are finalizing Covid economic recovery plans that the European Commission has stipulated must include strong climate- and clean energy-related components.

The analysis also found: increasing numbers of late-stage deals; major deals of €300 million or more in industries including batteries, electric mobility, shared mobility and the circular economy; and a sharp uptick in the number of deals in the materials and chemicals sector. Sign up for future quarterly briefings here.

The involvement of top venture capital firms in the Cleantech for Europe initiative underscores how important policy is to the success of cleantech innovation.

“The goal of the new initiative is to place cleantech innovation at the center of EU public policy debates in the coming weeks, months and years,” said Jules Besnainou, director at Cleantech Group, a research and consulting company that is helping organize the new group and author the quarterly briefings. “We want the bloc to capitalize on opportunities to build and expand clean industries, ensure a just transition, and mount a stronger response to a climate crisis which grows more urgent by the day.”

“The regulatory framework is critical for success in cleantech. We see it in hydrogen: strong policy moves result in market uptake.” added Ivo Němejc, Vice Chairman of the Board of Directors, Inven Capital

“It is still very hard for EU cleantech start-ups to scale beyond their national borders. If we want to lead the race to net zero, we need to start building continental champions.” said Martin Kröner, Managing Partner, Munich Venture Partners

“The energy transition is a systemic challenge, but also an opportunity for the EU to lead the world on climate innovation while creating high-quality jobs.” added René Savelsberg, Managing Partner and Co-Founder, SET Ventures

“To reach climate leadership, we must improve the funding cycle for EU cleantech. The time to act is now.” said Christian Reitberger, Partner, btov Industrial Tech Fund

“Our success in Estonia proves that efficient cooperation between policy-makers and cleantech leaders is in fact a must for sustainable innovation development.” added Erki Ani, CEO, Beamline Accelerator

Additional venture capital firms are expected to join the group in the coming months.

Specifically, the Cleantech for Europe initiative calls on the EU to:

  • Create a demand shock for green solutions. Create sectoral transition plans. Implement a predictable and progressive price on carbon. Accelerate green public procurement.
  • Support the creation of at least 10 EU scale-up funds. Increase non-dilutive funding. Leverage public-private instruments such as carbon contracts for difference.
  • Support cross-border scaling. Harmonize regulations and standards to allow innovative companies scale from one country to the continent. Develop integrated value chains across all member states.

In unveiling the investment tracker, Cleantech for Europe also announced that it will hold an inaugural Cleantech for Europe Summit on September 8, featuring key leaders from Europe’s venture capital and policy communities. The Summit will be opened by Pascal Canfin, MEP and Chair of the Committee on the Environment, Public Health and Food Safety at the European Parliament. To participate in the Summit, sign up here.

To set up interviews with European venture capitalists and innovators active in the cleantech space, and policy experts, or to get more of the backstory on how and why the Cleantech for Europe initiative was conceived, please contact Jules Besnainou at hello@cleantechforeurope.com

About Cleantech for Europe
Cleantech for Europe is an initiative created by Cleantech Group, supported by Breakthrough Energy and leading EU cleantech investors. Our mission is to help the EU lead the race to net zero while creating long-term industrial competitiveness. We aim to put innovation at the center of the public policy debate and build bridges between the EU’s cleantech community and policymakers in Brussels and member states.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press contact:
Jules Besnainou, hello@cleantechforeurope.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release

The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye